Intimation under Regulation 30 of the Listing Regulation
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals reported audited consolidated revenue of Rs 14,997.87 million for FY2026, up 15.2% from Rs 13,024.02 million in FY2025. Net profit after tax stood at Rs 1,941.87 million versus Rs 1,937.54 million, showing marginal growth. The Board declared an interim dividend of Rs 1 per share (10% on face value) with record date May 22, 2026, payable by June 13, 2026. Key corporate actions include a stock split where 1 share of Rs 10 face value will be subdivided into 5 shares of Rs 2 each. Dr. Ajay Thakker was appointed as Chairman & Whole Time Director. An exceptional item of Rs 48.87 million was recorded due to increased gratuity liability from new labour codes. Auditors issued an unmodified opinion. The merger of Medulla Healthcare Private Limited is pending NCLT approval.
Positive signals include steady revenue growth, clean audit opinion, shareholder-friendly stock split and dividend. The marginal PAT growth and exceptional item from labour code changes are minor concerns but do not indicate fundamental issues.